EP 157: Bridging genomics, business, and equity in healthcare access with Mark Taylor of LGC Group
October 17, 2024
In this episode, Patrick speaks with Mark Taylor, Head of Strategic Partnerships at LGC Group, about bridging the gap between genomics innovation and equitable healthcare. They discuss Mark's work with the National Institute for Health Research (NIHR), challenges in scaling precision therapies for the NHS, and strategies for engaging underrepresented populations.
Additionally, we’re excited to invite you to an in-person meet up for The Genetics Podcast during the ASHG Annual Meeting in Denver, CO! Over the years, we’ve had the honor of speaking with leading voices across science, industry, patient advocacy, and policy. Now, we’re bringing this incredible community together face-to-face. Join us on the evening of Thursday, November 7. To RSVP, visit: https://lu.ma/geneticspodASHG.
1:30 Intro to The Genetics Podcast
2:25 Welcome to Mark
3:10 Introduction to the National Institute for Health Research (NIHR)
4:05 Mark’s roles with the NIHR in strategic partnerships
7:35 Challenges patients face in accessing NHS resources and the NIHR’s efforts to streamline availability
13:25 How to scale breakthroughs in precision therapies so they are widely accessible to patients across the NHS: Top-down vs. bottom-up strategies
17:00 Applying principles of cost consequence analysis to NHS strategy
17:45 Misconceptions regarding NHS financing and the allocation of funding for medical innovations
23:20 Best practices for working with under- and mis-represented populations to facilitate development of and access to medical innovations
29:45 East London Genes & Health and Born in Bradford: Two cases where deep engagement and trust building resulted in robust data collection and innovation
32:45 Insights into the D Cyphr Program (DNA, Children, Young People’s Health Resource) aimed at gaining population-level genomic data to address broader health issues such as mental health and diabetes
34:35 Closing remarks